WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011135200) DERMATOLOGICAL COMPOSITION BASED ON ARGAN OIL AND HYALURONIC ACID
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/135200    International Application No.:    PCT/FR2011/000245
Publication Date: 03.11.2011 International Filing Date: 22.04.2011
IPC:
A61K 36/185 (2006.01), A61K 31/728 (2006.01), A61Q 19/00 (2006.01), A61P 17/00 (2006.01), A61K 8/73 (2006.01), A61K 8/97 (2006.01)
Applicants: AYAWANE [FR/FR]; 60 Avenue Rockfeller F-69008 Lyon (FR) (For All Designated States Except US).
DAHRI CORREIA, Latifa [FR/FR]; (FR) (For US Only)
Inventors: DAHRI CORREIA, Latifa; (FR)
Agent: IXAS CONSEIL; Schmidt, Martin Peter 15, rue Emile Zola F-69002 Lyon (FR)
Priority Data:
1001849 30.04.2010 FR
Title (EN) DERMATOLOGICAL COMPOSITION BASED ON ARGAN OIL AND HYALURONIC ACID
(FR) COMPOSITION DERMATOLOGIQUE À BASE D'HUILE D'ARGAN ET D'ACIDE HYALURONIQUE
Abstract: front page image
(EN)The invention relates to a composition, in particular in the form of a cream, ointment, balm or gel, for the topical treatment of the skin, including, in a physiologically acceptable medium: 1.0-50 wt % of argan oil, and 0.05-2.5 wt % of hyaluronic acid, the latter being present optionally in the form of a physiologically acceptable salt, and having a molecular weight of 400 kDa. The composition is used for the treatment of cutaneous injuries or cutaneous irritation.
(FR)Composition, notamment sous la forme d'une crème, pommade, baume ou d'un gel, pour le traitement topique de la peau, comprenant, dans un milieu physiologiquement acceptable; 1,0 à 50 % massiques d'huile d'argan, et 0,05 à 2,5 % massiques d'acide hyaluronique, ce dernier étant présent éventuellement sous la forme d'un sel physiologiquement acceptable, et possédant une masse moléculaire ne dépassant pas 400 kDa. La composition est utilisée pour le traitement de plaies cutanées ou de l'irritation cutanée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)